Arterial hypoxia Completed Phase 1 / 2 Trials for 5-(hydroxymethyl)-2-furaldehyde (DB12298)

Also known as: Hypoxia / Hypoxic

IndicationStatusPhase
DBCOND0023666 (Arterial hypoxia)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01871142Evaluation of the Attenuation by Aes-103 of Hypoxia Mediated Decrements in Endurance Exercise PerformancePrevention